Regeneron Pharmaceuticals Inc (REGN) - Financial and Strategic SWOT Analysis Review

Regeneron Pharmaceuticals Inc (REGN) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Regeneron Pharmaceuticals Inc (Regeneron) discovers, develops, manufactures, and markets medicines for the treatment of serious medical conditions. Its products are focused on helping patients suffering from cancer, allergic and inflammatory diseases, eye diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, hematologic conditions, pain, and rare diseases. Regeneron develops products using its Trap and VelociSuite technology platforms, which include VelocImmune, VelociGene, VelociMouse, VelociMab, Veloci-Bi, VelociT, and other related technologies. The company operates manufacturing facilities in Rensselaer, New York, and Limerick. It also collaborates with strategic partners to develop, manufacture and commercialize its products. The company sells its products to specialty pharmacies and distributors. It operates in the US, the Netherlands, Bermuda, Ireland, Spain, India, Japan and the UK. Regeneron is headquartered in Tarrytown, New York, the US.

Regeneron Pharmaceuticals Inc Key Recent Developments

May 22,2024: Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update
May 06,2024: Regeneron Announces Investor Conference Presentations
Apr 24,2024: Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
Feb 02,2024: Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Regeneron Pharmaceuticals Inc - Key Facts
Regeneron Pharmaceuticals Inc - Key Employees
Regeneron Pharmaceuticals Inc - Key Employee Biographies
Regeneron Pharmaceuticals Inc - Major Products and Services
Regeneron Pharmaceuticals Inc - History
Regeneron Pharmaceuticals Inc - Company Statement
Regeneron Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Business Unit
Section 2 – Company Analysis
Company Overview
Regeneron Pharmaceuticals Inc - Business Description
Other Break-up: Collaboration Revenue
Performance
Other Break-up: Net Product Sales
Performance
Other Break-up: Other Revenue
Performance
R&D Overview
Regeneron Pharmaceuticals Inc - Corporate Strategy
Regeneron Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Regeneron Pharmaceuticals Inc - Strengths
Regeneron Pharmaceuticals Inc - Weaknesses
Regeneron Pharmaceuticals Inc - Opportunities
Regeneron Pharmaceuticals Inc - Threats
Regeneron Pharmaceuticals Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Regeneron Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Regeneron Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Regeneron Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 22, 2024: Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update
May 06, 2024: Regeneron Announces Investor Conference Presentations
Apr 24, 2024: Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
Feb 02, 2024: Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
Jan 05, 2024: Regeneron to Report Fourth Quarter and Full Year 2023 Financial and Operating Results and Host Conference Call and Webcast on February 2, 2024
Nov 03, 2023: Regeneron to Highlight Scientific Advancements Across Diversified Pipeline in Difficult-to-Treat Blood Cancers and Disorders at ASH
Oct 04, 2023: Regeneron and Intellia expand partnership to develop CRISPR-based therapies
Sep 14, 2023: Signal- HHS-Regeneron Covid-19 deal includes list price clause for affordability
Sep 08, 2023: Regeneron Announces Updates to Board of Directors
Sep 08, 2023: Regeneron Provides Update on Planned Chief Financial Officer Transition
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Regeneron Pharmaceuticals Inc, Key Facts
Regeneron Pharmaceuticals Inc, Key Employees
Regeneron Pharmaceuticals Inc, Key Employees (cont..)
Regeneron Pharmaceuticals Inc, Key Employee Biographies
Regeneron Pharmaceuticals Inc, Major Products and Services
Regeneron Pharmaceuticals Inc, History
Regeneron Pharmaceuticals Inc, Other Locations
Regeneron Pharmaceuticals Inc, Subsidiaries
Regeneron Pharmaceuticals Inc, Business Unit
Regeneron Pharmaceuticals Inc, Key Competitors
Regeneron Pharmaceuticals Inc, Ratios based on current share price
Regeneron Pharmaceuticals Inc, Annual Ratios
Regeneron Pharmaceuticals Inc, Annual Ratios (Cont...1)
Regeneron Pharmaceuticals Inc, Annual Ratios (Cont...2)
Regeneron Pharmaceuticals Inc, Interim Ratios
Regeneron Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Regeneron Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Regeneron Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Regeneron Pharmaceuticals Inc, Performance Chart (2019 - 2023)
Regeneron Pharmaceuticals Inc, Ratio Charts
Regeneron Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Regeneron Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings